Search Results - Wenwen Guo

Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China by Jing Ni, Xianzhong Cheng, Rui Zhou, Xia Xu, Wenwen Guo, Xiaoxiang Chen

Connect to this object online.

Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series by Jing Ni, Rui Zhou, Xianzhong Cheng, Xia Xu, Wenwen Guo, Xiaoxiang Chen

Connect to this object online.

Age is associated with prognosis in serous ovarian carcinoma by Fei Deng, Xia Xu, Mengmeng Lv, Binhui Ren, Yan Wang, Wenwen Guo, Jifeng Feng, Xiaoxiang Chen

Connect to this object online.

Genomic alteration discordance in the paired primary-recurrent ovarian cancers: based on the comprehensive genomic profiling (CGP) analysis by Jiayin Dong, Jing Ni, Jiahui Chen, Xuening Wang, Luxin Ye, Xia Xu, Wenwen Guo, Xiaoxiang Chen

Connect to this object online.

The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China by Jing Ni, Xianzhong Cheng, Qian Zhao, Zhiqin Dai, Xia Xu, Wenwen Guo, Hongyuan Gu, Rui Zhou, Yan Wang, Xiaoxiang Chen

Connect to this object online.

Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway by Yan Ren, Yan Ren, Jie Wang, Wenwen Guo, Jingwen Chen, Jingwen Chen, Xin Wu, Xin Wu, Shubo Gu, Lizhi Xu, Lizhi Xu, Zhiwei Wu, Zhiwei Wu, Yaping Wang, Yaping Wang

Connect to this object online.